Oncology Data Advisor
J

Understanding the Tumor Microenvironment to Unlock the Key to Oncology Drug Development

By Oncology Data Advisor FEATURING Jesus Garcia
By Oncology Data Advisor FEATURING Jesus Garcia
0 views
October 9, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
19:05
International Congress on Cancer Metastasis

Could We Cure Metastatic Breast Cancer?

Feat. L. Pusztai
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
67:04
European School of Oncology

Basic Principles of Tumor Immunology

Feat. M. van den Broek
24:44
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

Successes and Challenges of Early Drug Development for Brain Metasta…

Feat. A. Drilon
24:23
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis

Characterizing the Immune Microenvironments of Brain Metastases

Feat. P. Siegel
29:07
Oncology Data Advisor

Accelerated Approvals in Oncology: Benefits, Risks, and the Way Forw…

Feat. J. Mouabbi, R. Maclean, M. Glover
50:56
UNC Lineberger Comprehensive Cancer Center

2024 Update in Oncologic Emergencies

Feat. J. Stein
11:26
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Bispecific

Feat. J. Gulley
15:31
Shivaani Kummar

Clinical Implications of Tumor Agnostic Therapies

20:06
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Combination Therapy

Feat. A. Patnaik
20:12
OncoAlert

Geriatric Oncology Updates: Guidelines and Priorities for Older Pati…

Feat. L. Decoster
16:18
ImmunoTherapy Bridge 2023

Innovating Immunotherapy for Pancreatic Cancer

Feat. G. Lesinski
16:02
ImmunoTherapy Bridge 2023

Novel Insights Into the Mechanisms of Radiation-Induced Anti-Tumor I…

Feat. S. Demaria
48:12
Yale Cancer Center

Lymphocytes as a "Living Drug" for the Treatment of Cancer

Feat. S. Rosenberg
12:22
Melanoma Bridge 2023

Drug Development in Melanoma: Phase I/II/III vs. Novel Designs

Feat. I. Puzanov
50:11
UNC Lineberger Comprehensive Cancer Center

Integrating Germline Pharmacogenomic Testing Into Oncology Care

Feat. A. Cipriani
34:57
Total Health

2023 ASCO® Direct Philadelphia: Complementary & Integrative Ther…

Feat. B. DuPree
17:27
Louisville Hematology Highlights

Using Tumor Infiltrating Lymphocytes to Induce Solid Tumor Regression

Feat. J. Chesney
12:21
ImmunoTherapy Bridge 2023

Immunotherapy for HCC: Current Status & Future Perspectives

Feat. P. Federico